Seok Joon Kwon

Seok Joon Kwon

Auto-generated profile, based on publicly available information

Seok Joon Kwon

Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2019 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
PKPaul S. Kwon
Paul S. Kwon
SRShaokang Ren
Shaokang Ren
SKSeok-Joon Kwon
Seok-Joon Kwon
MKMegan E. Kizer
Megan E. Kizer
LKLili Kuo
Lili Kuo
XWXing Wang
Xing Wang

24 October 2016 in Nature Nanotechnology
Verified
Journal Article
Closed access
SKSeok-Joon Kwon
Seok-Joon Kwon
Dong Hee NaDong Hee Na
Dong Hee Na
JKJong Hwan Kwak
Jong Hwan Kwak
MDMarc Douaisi
Marc Douaisi
FZFuming Zhang
Fuming Zhang
RLRobert J. Linhardt
Robert J. Linhardt

4 March 2010 in ACS Nano
Verified
Journal Article
Closed access
SBShyam Sundhar Bale
Shyam Sundhar Bale
SKSeok Joon Kwon
Seok Joon Kwon
DSDhiral A. Shah
Dhiral A. Shah
ABAkhilesh Banerjee
Akhilesh Banerjee
JDJonathan S. Dordick
Jonathan S. Dordick
RKRavi S. Kane
Ravi S. Kane

28 February 2016 in Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
GNGregory Nierode
Gregory Nierode
PKPaul S. Kwon
Paul S. Kwon
JDJonathan S. Dordick
Jonathan S. Dordick
SKSeok-Joon Kwon
Seok-Joon Kwon
To reduce attrition in drug development, it is crucial to consider the development and implementation of translational phenotypic assays as well as decipher diverse molecular mechanisms of action for new molecular entities. High-throughput fluorescence and confocal microscopes with advanced analysis software have simplified the simultaneous identification and quantification of various cellular processes through what is now referred to as highcontent screening (HCS). HCS permits automated identification of modifiers of accessible and biologically relevant targets and can thus be used to detect gene interactions or identify toxic pathways of drug candidates to improve drug discovery and development processes. In this review, we summarize several HCS-compatible, biochemical, and molecular biology-driven assays, including immunohistochemistry, RNAi, reporter gene assay, CRISPR-Cas9 system, and protein-protein interactions to assess a variety of cellular processes, including proliferation, morphological changes, protein expression, localization, post-translational modifications, and protein-protein interactions. These cell-based assay methods can be applied to not only 2D cell culture but also 3D cell culture systems in a high-throughput manner.

12 January 2010 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
Tiago FernandesTiago Fernandes
Tiago Fernandes
SKSeok‐Joon Kwon
Seok‐Joon Kwon
SBShyam Sundhar Bale
Shyam Sundhar Bale
MLMoo‐Yeal Lee
Moo‐Yeal Lee
Maria Margarida DiogoMaria Margarida Diogo
Maria Margarida Diogo
JDJonathan Dordick
Jonathan Dordick

6 May 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
SKSeok Joon Kwon
Seok Joon Kwon
DLDong Woo Lee
Dong Woo Lee
DSDhiral A. Shah
Dhiral A. Shah
BKBosung Ku
Bosung Ku
SJSang Youl Jeon
Sang Youl Jeon
MLMoo-Yeal Lee
Moo-Yeal Lee
Differential expression of various drug-metabolizing enzymes (DMEs) in the human liver may cause deviations of pharmacokinetic profiles, resulting in interindividual variability of drug toxicity and/or efficacy. Here, we present the ‘Transfected Enzyme and Metabolism Chip’ (TeamChip), which predicts potential metabolism-induced drug or drug-candidate toxicity. The TeamChip is prepared by delivering genes into miniaturized three-dimensional cellular microarrays on a micropillar chip using recombinant adenoviruses in a complementary microwell chip. The device enables users to manipulate the expression of individual and multiple human metabolizing-enzyme genes (such as CYP3A4, CYP2D6, CYP2C9, CYP1A2, CYP2E1 and UGT1A4) in THLE-2 cell microarrays. To identify specific enzymes involved in drug detoxification, we created 84 combinations of metabolic-gene expressions in a combinatorial fashion on a single microarray. Thus, the TeamChip platform can provide critical information necessary for evaluating metabolism-induced toxicity in a high-throughput manner.